Migraines: Can Cannabis Help?

In this interactive workshop we will discuss how to treat migraines with cannabis.

Migraines are the third-most prevalent medical condition in the world, and they’re three times more likely to affect woman then men. Migraines are not only painful, but can be extremely debilitating. Ninety percent of migraine sufferers can’t work or complete daily activities and many migraines can last up to 72 hours.

The good news: new research indicates that cannabis can provide significant relief for migraine sufferers. One such study indicates that 85% of migraine sufferers saw a decrease in the frequency and severity of migraines. At the same time, around 20% of migraine sufferers indicated that cannabis helped prevent migraines altogether.

In this interactive discussion, HelloMD’s co-founder Pamela Hadfield will speak with Alison Ettel, the Founder of Treatwell, to learn the “what” and the “how” of treating migraines with cannabis. We will discuss how to effectively manage migraine pain with cannabis and how to possibly prevent them altogether. Some of the questions we will cover in this workshop:

How does cannabis work within our bodies?

Why does cannabis help to alleviate migraines?

What part do cannabinoids play in the treatment of migraines?

How does cannabis help manage pain in lieu of pharmaceuticals?

What cannabis products work best in the treatment of migraines?

Do I need to be “high” in order to treat my migraines?

Pamela Hadfield started HelloMD after successfully treating and then preventing her own migraines with cannabis. Alison Ettel has worked with migraine patients across CA and through observational data has seen the results that cannabis may provide.

This fireside chat will be followed by an audience Q&A where everyone has a chance to ask their questions.

This event is free to attend and is a non-consumption event.

Event Format

5:45pm Doors open/Meet and greet with wine and nibblies

6:00pm - 6:45pm Fireside chat with Alison Ettel of Treatwell

6:45pm - 7:15pm Q&A with audience

7:30 Doors close

About Treatwell:

TreatWell was founded in 2015 to provide the highest-quality cannabis products for both people and pets. The company specializes in non-psychoactive options for medicating with cannabis including high-CBD ratios and raw acidic compounds. The brand is on the cutting edge of marijuana research, as well as incorporating the latest techniques to better help patients. TreatWell believes in pursuing the highest quality from seed to final product, which results in a better-tasting and more-effective product.

Presenter: Alison Ettel

Alison Ettel is the CEO and Founder of Treatwell Health, one of the most popular and respected cannabis brands in California. Alison has a varied professional background from Wall St. to think tanks plus gaining a few masters degrees in between. Her true calling, however, came after trying cannabis while recovering from a coma from meningitis. After studying and researching the plant, she became passionate about providing high quality cannabis medicine for others and to raise the bar for the industry overall. Alison uses years of anecdotal data from Treatwell’s extensive patient database in conjunction with research and scientific data to consistently innovate product development beyond the industry standard.

Presenter: Pamela Hadfield

Pamela Hadfield is a tech entrepreneur and co-founder of HelloMD, the largest online community of health and wellness cannabis consumers. After treating her debilitating migraines with cannabis successfully, Pamela launched HelloMD in order to help other people find a sense of health and wellness through cannabis. Her passion is to educate others about the potential cannabis holds as a tool for overall health and wellness. As a leading female executive and spokesperson for one the fastest growing industries in the world, Pamela has been featured in publications including Forbes, The New York Times, Elle, Rolling Stone, ADR, Cannabis Now, Harper’s Bazaar, LA Weekly, Marie Claire, TechCrunch, CBS Sunday News and more.